Rags to Riches

[levelnever]

Updated DD on IQMC (2/23/10)

**I am writing this post to help serve as a centralized hub for all things IQMC, to collect all the DD people have done and hopefully serve as a launching board for investors to start their own DD. It is long as I try to be thorough take it piece by piece if you like. I will do my best to provide links so you can follow where the research is coming from and I have also tried to provide some screenshots for additional information as well. As the IQMC story unfolds I will continue to update this post. Please let me know either if you see any mistakes or you believe I've left anything important off. As always this is not meant to supplant your own DD, only complement it. Be aware that mixed in with facts here there is speculation. Do your own research to either back up or refute mine, the more we know the better. Below, I do my best to spell out the IQMC story as I understand it. At the end of this post I also attempt to lay out the concerns or things we don't currently know.



Until recently advances in microfluidics technology has begun to take the field away from just one of academic pursuit and scientific jargon into a realm of commercial possiblities. As the MIT Technology Review said in 2008: (Article referenced linked to in section below)

Microfluidics, the science of systems that can manipulate extremely small volumes of liquids, has been named by MIT Technology Review as one of the ten technologies that will change the world.

And this is where IQMC and its partners come in. While we haven't heard from IQMC in the last couple years, the trading activity and the developments with IQMC partners Osmotex and Lifecare has peaked my interest.


IQ MICRO

About:

From their last SEC filing:

IQ Micro Inc. is an international licensing company that commercializes proprietary technology developed for use in the microfluidics sector. Developed from the micro-chip industry, microfluidics involves circuits of tiny chambers, channels and pumps that direct the flow of liquids on a single micro-chip.

IQ Micro is actively pursuing global licensing opportunities for its patented electro-osmotic membrane technology and its "invisible pump," a microfluidic technology with a wide range of consumer, medical and industrial applications. With its proprietary technology and highly experienced management, IQ Micro expects to become a leading global, specialized supplier of low-voltage microfluidic technology.

Share Structure:

Last reported O/S 51,223,991 (June 30, 2007)
Last reported A/S 300,000,000 (June 30, 2007)
Current Market Cap: $107,570


Incorporation Documentation:



http://www.sos.state.co.us/biz/BusinessEntityDetail.do?quitButtonDestination=BusinessEntityResults&nameTyp=ENT&masterFileId=20041038137&entityId2=20041038137&srchTyp=ENTITY&fileId=20051369976


What are the basics of Microfluidics?

Simply put, microfluidics technology is designing ways to manipulate and control water on a micro level. You would think this sounds easy enough. But the problem is water acts differently when operating at micro scale, as opposed to a macro scale. This is because surface tension, viscosity, and electrical charges can become dominant forces on a fluid because the surface-to-volume ratio is much greater than for macroscale systems. So while you still need much of the same macro-scale technology to control water (including pumps, valves, mixers, filters, and separators), because water going through a micro-channel behaves differently these items need to be modified. That is where IQ Micro and its partners come in. They have established a strong patent portfolio and are developing technology in this arena.

If you want a more thorough and detailed description of microfluidics and micropumps read this article from MIT Technology Review (9/08):

http://docs.google.com/viewer?a=v&q=cache:1mxFC870cJ4J:www.ll.mit.edu/publications/technotes/TechNote_Micropumps.pdf+micropumps&hl=en&gl=us&pid=bl&srcid=ADGEESipJYsET3zpaBl7t0eJtWQvxS3Iar8dqVWQWJKP4I5jVaJhxF8ki9mURQv9d91vpfT_kQItlcX81TyRWOXQXTz1LLLEsqicYLStma_PaMxA81JeqZoCiaMdsoS1gY4xAqsEJWJX&sig=AHIEtbTzvyFenZoYog13pRQchCHf_65-KQ

Here's another more easily digestible explanation from The Industrial Physcist:

http://www.aip.org/tip/INPHFA/vol-9/iss-4/p14.html


Why might this technology be game changing?

As MIT Technology Review pointed out, some academics see microfluidics technology as potentially game changing, yet it is still very much under the radar and only in the last two years have the commercial breakthrough's begun to occur. As Swiss Center of Electronics and Microtechnology (CSEM) scientist Helmut Knapp says in an Osmotex article linked to below: "So far, the failure to break through commercially with these devices has to do with a lack of reliable fluidic actuators, ie Pumps, at a cost where the devices can be integrated." This is exactly where IQMC and it's partners come in (micro-pumps) and why microfluidics technology some believe is on the cusp of breaking out.

From wikipedia:

Advances in microfluidics technology are revolutionizing molecular biology procedures for enzymatic analysis (e.g., glucose and lactate assays), DNA analysis (e.g., polymerase chain reaction and high-throughput sequencing), and proteomics. The basic idea of microfluidic biochips is to integrate assay operations such as detection, as well as sample pre-treatment and sample preparation on one chip.[3][4]

An emerging application area for biochips is clinical pathology, especially the immediate point-of-care diagnosis of diseases. In addition, microfluidics-baseddevices, capable of continuous sampling and real-time testing of air/water samples for biochemical toxins and other dangerous pathogens, can serve as an always-on "bio-smoke alarm" for early warning.

Does IQMC actually develop the microfluidics technology?

No, they actually serve as the licensing arm for Swiss company Osmotex and Norwegian company Lifecare AS. In that sense, the technology that Osmotex and Lifecare develops IQ Micro will take to potential customers and pursue potential global licensing opportunities. That said, there is a little interesting caveat to this which is under the we don't know section on the bottom of this recap.


Can just licensing microfluidics technology be profitable?

In such a small niche market like the market for microfluidics technology at the moment licensing is perhaps the most lucrative direction. Research institutions, like Osmotex and its partners have developed technology and established patents that big players might be interested in.

The most recent example of microfluidics technology being licensed out was Caliper Life Sciences licensing out their microfluidics technology to Becton Dickinson (January 11, 2010).

http://www.genomeweb.com/pcrsample-prep/caliper-licenses-microfluidics-ip-bd-settling-handylab-lawsuit



OSMOTEX





Here is when the partnership began between IQMC and Osmotex:

On June 9, 2005, the Company (IQ Micro) commenced development activities when it acquired exclusive, worldwide sales and marketing licensing rights to microfluidics technology developed and patented by Osmotex AS ("Osmotex"), incorporated in Norway in 1999, as well as additional intellectual property rights of Osmotex together with such patents, (the "Licensed Rights").

Who is Osmotex?

From their website:
http://www.osmotex.ch

Osmotex is an innovative company dedicated to delivering the most advanced and useful pumps for the emerging science and technology of microfluidics. We produce generic micropumps for fuel cells, life-sciences and chemical research, and do also engage in application specific development with partners.

Research Partners

They have well respected institutions backing them up:

Osmotex AG is located together with its long term research partner, the Swiss Center of Electronics and Microtechnology (CSEM) in Central Switzerland. Osmotex' research started at the Norwegian Institute of Science and Technology (NTNU) in 1999.

http://www.ntnu.no/english
http://www.csem.ch/site/

Here is a recent picture of Dr. Tormod Volden of Osmotex working with Dr. Helmut Knapp of CSEM.



Osmotex's Patent Porfolio

8/13/09 - ELECTRO-OSMOTIC PUMP
http://www.wipo.int/pctdb/en/fetch.jsp?LANG=ENG&DBSELECT=PCT&SERVER_TYPE=19-10&SORT=41268796-KEY&TYPE_FIELD=256&IDB=0&IDOC=588657&C=10&ELEMENT_SET=B&RESULT=1&TOTAL=3&START=1&DISP=25&FORM=SEP-0/HITNUM,B-ENG,DP,MC,AN,PA,ABSUM-ENG&SEARCH_IA=GB2009000355&QUERY=(FP/osmotex)+

2/26/09 - TEXTILE HAVING WATER TRANSPORT AND HEATING CAPABILITIES
http://www.wipo.int/pctdb/en/fetch.jsp?LANG=ENG&DBSELECT=PCT&SERVER_TYPE=19-10&SORT=41269125-KEY&TYPE_FIELD=256&IDB=0&IDOC=585802&C=10&ELEMENT_SET=B&RESULT=1&TOTAL=1&START=1&DISP=25&FORM=SEP-0/HITNUM,B-ENG,DP,MC,AN,PA,ABSUM-ENG&SEARCH_IA=GB2008002815&QUERY=(FP/osmolife)+ (through parent company Osmolife)

1/22/04 - ACTUATOR IN A MICROFLUIDIC SYSTEM FOR INDUCING ELECTROOSMOTIC LIQUID MOVEMENT IN A MICRO CHANNEL
http://www.wipo.int/pctdb/en/fetch.jsp?LANG=ENG&DBSELECT=PCT&SERVER_TYPE=19-10&SORT=41268796-KEY&TYPE_FIELD=256&IDB=0&IDOC=985752&C=10&ELEMENT_SET=B&RESULT=2&TOTAL=3&START=1&DISP=25&FORM=SEP-0/HITNUM,B-ENG,DP,MC,AN,PA,ABSUM-ENG&SEARCH_IA=NO2003000246&QUERY=(FP/osmotex)+

1/22/04 - FABRIC MATERIAL WITH IMPROVED LIQUID TRANSPORT
http://www.wipo.int/pctdb/en/fetch.jsp?LANG=ENG&DBSELECT=PCT&SERVER_TYPE=19-10&SORT=41268796-KEY&TYPE_FIELD=256&IDB=0&IDOC=985753&C=10&ELEMENT_SET=B&RESULT=3&TOTAL=3&START=1&DISP=25&FORM=SEP-0/HITNUM,B-ENG,DP,MC,AN,PA,ABSUM-ENG&SEARCH_IA=NO2003000247&QUERY=(FP/osmotex)+


Investor Information

Here is more information on one investment company which has invested in Osmotex:

Jade Invest SA



http://www.jade-invest.ch/mission.html
http://www.jade-invest.ch/portfolio.html

Slide Show published 3 months ago:
http://www.slideshare.net/nseverin/innovation1

Article from San Diego Business Site mentions Jade Invest SA (December 24, 2009):
http://www.xconomy.com/san-diego/2009/12/24/ringing-in-the-new-year-five-san-diego-tech-companies-raise-cash-in-december/

Banque Bonhôte invests CHF 20 million in the capital of Jade SA (October 1, 2009):
http://docs.google.com/viewer?a=v&q=cache:lYebcMXZy-MJ:www.csem.ch/docs/Show.aspx%3Fid%3D11014+"jade+invest"&hl=en&gl=us&pid=bl&srcid=ADGEESgWIqfjpmB1ntUifvqCDXimwxerUmcbtzpTkTJGLgY_OtE4WEWWwZieCJMCO8q-g5MV9t7bJ994e19SE8lyfkUeBelwRSjGad7RsDuphzfbfxs2nS3NInEnZbvJBbLra61TSZmr&sig=AHIEtbRJb3CQnwEhHK8N1jofDj_ie_kVug


What have they been up to lately?

If you want to get the best sense of what Osmotex has been up to lately you should read these translated articles. These articles spell it all out pretty clearly, much better than I could and give you a much better sense of what they are up to:

"Using electrokinesis is the trick with advanced micro-pumps" - Innovation Journal
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=46322379

"Battery or Superfluous Battery" - Handelszeitung & The Wall Street Journal
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=46669446


What products do they currently have available?

Screenshot of products page (first line of products):



Marketing material for their first line of products:







Or it you want to see a couple videos of a demonstration of some of their products. here are two links. The videos are embedded in these pages:

Textile Micro-pump: http://www.osmotex.ch/en/products/textile_pump/

Pump-on-Chip: http://www.osmotex.ch/en/products/pump-on-a-chip/



LIFECARE





Here is when that partnership began between IQMC and Lifecare AS:

IQ Micro Inc. (OTCBB: IQMC), exclusive licensor of patented electro-osmotic membranes and micro-pumps for the rapidly emerging microfluidic technologysector, announced today that its parent company, Osmotex AS, has merged with Lifecare AS, a private Norwegian company developing advanced micro and nanotechnology for the diabetes monitoring market. The expanded parent company, renamed Osmolife AS, will continue to function as a holding company for two research and development subsidiaries and for IQ Micro, its exclusive, worldwide sales and marketing company.

About:

Lifecare AS is focused on developing the next generation of glucose devices.
http://www.lifecare.no

For more information on the field of Biomedical Sensors and it's relation to Lifecare this is an interesting article on Biomedical Sensors which references Lifecare at the end.
http://docs.google.com/viewer?a=v&q=cache:Aj1t9F-8gqYJ:www.sintef.no/project/FOBIS/FOBIS%2520newsletter%2520Aug06.pdf+sencell+lifecare&hl=en&gl=us&pid=bl&srcid=ADGEESgJfhOSVDNgubv-5IHYmEKWIZ4Q4JJVXJ286kCCBu2bUchVTkmbq3lL9hzkCIyo9iPGI86OuC-KUbvZI7lwwxlQ_MNBGUgEZV_eQrcDXBkHy3F2q7XTjWTct5rzYXN60ukruUxJ&sig=AHIEtbQIl45J0KgatejuftWiw6_ckQGvGA


Research Partners:

Kelvin Nanotechnologies, University of Glasgow (Scotland)
University of Oslo, Institute of Informatics (Norway)
CSEM (Switzerland)
Rikshospitalet University Hospital, Institute of Immunology (Norway)
VTT Institute of Technology (Finland)
Vestfold University College (Norway)
TNO (Netherlands)


Lifecare's Patent Portfolio

2/26/09 - APPARATUS AND METHOD FOR MEASURING AUGMENTED OSMOTIC PRESSURE IN A REFERENCE CAVITY
http://www.wipo.int/pctdb/en/fetch.jsp?LANG=ENG&DBSELECT=PCT&SERVER_TYPE=19-10&SORT=41267434-KEY&TYPE_FIELD=256&IDB=0&IDOC=988035&C=10&ELEMENT_SET=B&RESULT=1&TOTAL=8&START=1&DISP=25&FORM=SEP-0/HITNUM,B-ENG,DP,MC,AN,PA,ABSUM-ENG&SEARCH_IA=NO2008000295&QUERY=(FP/lifecare+AND+FP/as)+

9/12/08 - FABRICATION OF REINFORCED NANOPOROUS MEMBRANES
http://www.wipo.int/pctdb/en/fetch.jsp?LANG=ENG&DBSELECT=PCT&SERVER_TYPE=19-10&SORT=41267434-KEY&TYPE_FIELD=256&IDB=0&IDOC=987831&C=10&ELEMENT_SET=B&RESULT=2&TOTAL=8&START=1&DISP=25&FORM=SEP-0/HITNUM,B-ENG,DP,MC,AN,PA,ABSUM-ENG&SEARCH_IA=NO2008000085&QUERY=(FP/lifecare+AND+FP/as)+

12/16/04 - SENSOR IN VIVO MEASUREMENT OF OSMOTIC CHANGES
http://www.wipo.int/pctdb/en/fetch.jsp?LANG=ENG&DBSELECT=PCT&SERVER_TYPE=19-10&SORT=41267434-KEY&TYPE_FIELD=256&IDB=0&IDOC=986102&C=10&ELEMENT_SET=B&RESULT=4&TOTAL=8&START=1&DISP=25&FORM=SEP-0/HITNUM,B-ENG,DP,MC,AN,PA,ABSUM-ENG&SEARCH_IA=NO2004000166&QUERY=(FP/lifecare+AND+FP/as)+

1/21/00 - SELF-DESTRUCTING NEEDLE HOLDER FOR INJECTION SYRINGES OR THE LIKE
http://www.wipo.int/pctdb/en/fetch.jsp?LANG=ENG&DBSELECT=PCT&SERVER_TYPE=19-10&SORT=41267434-KEY&TYPE_FIELD=256&IDB=0&IDOC=983958&C=10&ELEMENT_SET=B&RESULT=5&TOTAL=8&START=1&DISP=25&FORM=SEP-0/HITNUM,B-ENG,DP,MC,AN,PA,ABSUM-ENG&SEARCH_IA=NO1999000218&QUERY=(FP/lifecare+AND+FP/as)+

5/28/99 - ARRANGEMENT IN A NEEDLE HOLDER FOR A SELF-DESTRUCTING SYRINGE
http://www.wipo.int/pctdb/en/fetch.jsp?LANG=ENG&DBSELECT=PCT&SERVER_TYPE=19-10&SORT=41267434-KEY&TYPE_FIELD=256&IDB=0&IDOC=983695&C=10&ELEMENT_SET=B&RESULT=6&TOTAL=8&START=1&DISP=25&FORM=SEP-0/HITNUM,B-ENG,DP,MC,AN,PA,ABSUM-ENG&SEARCH_IA=NO1998000333&QUERY=(FP/lifecare+AND+FP/as)+

8/13/98 - SELF-DESTRUCTING HYPODERMIC SYRINGE
http://www.wipo.int/pctdb/en/fetch.jsp?LANG=ENG&DBSELECT=PCT&SERVER_TYPE=19-10&SORT=41267434-KEY&TYPE_FIELD=256&IDB=0&IDOC=983421&C=10&ELEMENT_SET=B&RESULT=7&TOTAL=8&START=1&DISP=25&FORM=SEP-0/HITNUM,B-ENG,DP,MC,AN,PA,ABSUM-ENG&SEARCH_IA=NO1998000042&QUERY=(FP/lifecare+AND+FP/as)+

7/15/98 - METHOD FOR MONITORING THE LEVEL OF AN OSMOTICALLY ACTIVE COMPONENT IN BODY FLUID AND DEVICE FOR CARRYING OUT SAID METHOD
http://www.wipo.int/pctdb/en/fetch.jsp?LANG=ENG&DBSELECT=PCT&SERVER_TYPE=19-10&SORT=41267434-KEY&TYPE_FIELD=256&IDB=0&IDOC=983378&C=10&ELEMENT_SET=B&RESULT=8&TOTAL=8&START=1&DISP=25&FORM=SEP-0/HITNUM,B-ENG,DP,MC,AN,PA,ABSUM-ENG&SEARCH_IA=NO1997000349&QUERY=(FP/lifecare+AND+FP/as)+


Investor Information:

They were awarded a $2 million grant from the Research Council of Norway a few years back:
http://www.nanotech-now.com/news.cgi?story_id=23822
July 12th, 2007


What have they been up to lately?

A few months ago, at the beginning of November 2009 there was the Diabetes Technology Society Meeting in Brussels, Belgium. At the meeting Lifecare AS presented Sencell, a new glucose monitoring device they have been working on. Since then this product has been generating some buzz in the diabetes community as evidenced by the press and coverage below:

http://www.diabetesmine.com/2009/11/diabetes-technology-society-on-the-horizon.html
http://diabetesnewshound.com/uncategorized/six-new-diabetes-technologies-currently-under-development/
http://translate.google.com/translate?hl=en&sl=fr&u=http://www.vivreavecundiabete.com/blog/%3Fp%3D849&ei=GAFeS5jgO8Wg8Aaf3rn-BA&sa=X&oi=translate&ct=result&resnum=1&ved=0CAkQ7gEwAA&prev=/search%3Fq%3Dhttp://www.vivreavecundiabete.com/blog/%253Fp%253D849%26hl%3Den%26sa%3DG

Sencell is done with development and currently in testing phase:

The prototypes of the SENCELL are in October 2009 going through laboratory in vitro testing to verify performance data.

What is Sencell?



Here's how it works. First a small chip is inserted into the skin using a syringe. It is a few millimeters big and serves as a glucose sensor. The way it is able to gauge glucose levels is osmotic pressure using Osmotex's microfluidics technology. Based on this technology and the initial buzz it has been receiving you can see how this basic premise could be expanded out beyond just glucose devices.

Here is an excerpt from some press:

Injectable Continuous Ostomotic Glucose Sensor – LifeCare AS out of Bergen, Norway, is working on a CGM that’s so tiny it can be implanted without surgery. The product is called SENCELL, and will be injected under the skin on your wrist. The technology is based on osmotic pressure, but please don’t ask me to explain the science behind it; something about a “reversible competitive affinity assay” that recognizes changes in glucose levels, and then wirelessly transmits them to an external receiver. All I know now is that the company claims it’s the “new frontier in CGM!” SENCELL is currently undergoing laboratory in vitro testing to determine reactions from the immune system. Hmmm.

OSMOLIFE

The final part of the story is perhaps the most intriguing part of the story, yet also leads into the things we don't know. In the end according to the following PR, Lifecare and Osmotex were put under the umbrella of a parent company Osmolife.

http://newsblaze.com/story/2007052106005900022.mwir/topstory.html

IQ Micro Inc. (OTCBB: IQMC), exclusive licensor of patented electro-osmotic membranes and micro-pumps for the rapidly emerging microfluidic technology sector, announced today that its parent company, Osmotex AS, has merged with Lifecare AS, a private Norwegian company developing advanced micro and nanotechnology for the diabetes monitoring market. The expanded parent company, renamed Osmolife AS, will continue to function as a holding company for two research and development subsidiaries and for IQ Micro, its exclusive, worldwide sales and marketing company.

That said, one of the last official comminique's we got from the company is a bit intriguing to say the least. It seems to imply that IQMC acquired Lifecare AS outstanding shares in an effort to strengthen IQMC's position to bring Sencell to market when it was ready. Well, as of November and the presentation at the Diabetes Conference Sencell looks ready.

IQ Micro Inc., exclusive licensor of patented electro-osmotic membranes and micro-pumps for the microfluidic technology sector, has entered an agreement in principle with its parent company, Osmolife AS, to acquire all of the issued and outstanding shares of Lifecare AS. A private Norwegian company, Lifecare is developing advanced micro and nanotechnology for the diabetes monitoring market. The proposed transaction is scheduled to close on July 15, 2007.

IQ Micro President and CEO, Johnny Christiansen, said, "With this acquisition, IQ Micro will strengthen its position in the $11 billion worldwide diabetes market by gaining immediate access to the parent company's proprietary technologies. As we continue to commercialize our licensed microfluidics technologies, Lifecare's patented technology will create another important building block in the future of diabetes treatment for the company."

Lifecare has been developing an implantable osmotic sensor for automated, continuous glucose monitoring. The company's proprietary sensor, SENCELL, promises precision and accuracy beyond existing solutions. SENCELL integrates micro and nanofabrication technologies into a tiny device that provides a platform for development of a long-term, in vivo glucose sensor solution to replace conventional, less efficient glucose monitoring and measurement techniques.

TRADING ACTIVITY & CHART


Please note all stock related chart information as of February 23, 2010:

Weekly Chart:




Daily Chart:




Barchart.com:

http://barchart.com/technicals/IQMC




StockTA:

http://www.stockta.com/cgi-bin/analysis.pl?symb=IQMC&num1=1&cobrand=&mode=stock





Why has trading been so tight?

There is some indication that Osmolife may own nearly 85% of IQMC common stock. I do question the validity of this and only consider this possiblity because of how tight the shares have been, implying a low float. The rumor comes from the PR below, but all the connections aren't quite clear here and it is not certain if Osmolife currently has acquired stake. If anyone can clarify this anymore would be greatly appreciated. If it were proven to be true it would mean heavy, heavy inside ownership which is always a nice thing.

In the CC Agreement, we agreed to exchange 42,670,000 shares of our $0.0001 par value per share common stock to Osmotex USA in return for the Licensed Rights. As a result of this transaction, Osmotex USA became the beneficial owner of approximately 85% of our capital stock.

CONCERNS & WHAT WE DON'T KNOW


Are there concerns?

Absolutely, as with any pink, especially at these trading levels.


(1) Lack of current information from company.

The main concern here of course is the lack of information from the company for the last couple years. For all I know, Osmotex and Lifecare may have ditched IQ Micro a few years ago, although there aren't any indications that this is the case. It is still an active company incorporated in Colorado. There has been talk among some investors that there may be a R/M, but I'm not convinced that this will be the case. A plausible scenario I have heard is that perhaps management has been instead focusing on helping Osmotex and Lifecare develop their technology. Now that products are just coming to market, maybe IQMC gets going again? But these are hypotheticals, until we hear from the company there is just no way of truly knowing.

This all said that is the game you are playing when you are playing a stock at these levels. Certainty is almost impossible to come by. On a sidenote, it has been hard to track down current share numbers. If anyone can help in this process it would be incredibly useful. My gut says that the O/S is most likely larger based off of previously arranged financing, but we will hopefully find that out. And last we knew the A/S was 300,000,000.


(2) Reverse splits

There was a reverse split done on the symbol of 200:1 on November 5, 2004. This however was prior to IQ Micro's existence and the management is totally different so I do not think this is a concern.


(3) The distance between many of the key personnel and IQ Micro

Our Chief Executive Officer, Johnny Christiansen, and our Chief Operations Officer, Per Arne Lislien, are Norwegian citizens who reside full-time in Norway. Given their physical distance from our office in Florida, their command of English as their second language and the six-hour time difference from that of our Florida office, we may not always be able to communicate with them in a timely or effective manner.

This distance may have something to do with Concern #1, the lack of information from the company. With management in Norway and who may not speak English that well, you can imagine why we might not be hearing anything. Hopefully they can bring IQMC back to life and hire someone in the states to release more PR on their developments.


My Take:

In the end, IQMC is a risky play like many pinks and especially stocks at these valuations, but for a stock with such potential I still think this is undervalued. With so much meat on the bones, there will be plenty of potential DD and research that should keep this stock moving up (at what pace who knows). And the reward if we do get news could be huge and far outweighs the risk IMO. With the press and buzz surrounding Sencell and Osmotex's new products, the close relationship Osmotex and Lifecare maintain with well respected academic institutions throughout Europe and the potential of its microfluidics technology, it makes IQMC a potential long play. At the very least, if and when volume starts to come in, I know that the story and potential behind this stock are significant enough for it to run. And if we add news and IQMC comes out of hibernation this has potential for a blockbuster move.